A single IVF cycle can cost a patient $20,000 to $30,000, and a donor-egg cycle can push past $60,000 once agency fees, screening, and cryostorage are added on. From the patient's checkbook, that is one large invoice. From the clinic's general ledger, it is something far more complicated: a multi-element arrangement with retrieval, lab work, transfer, freezing, storage, and a contingent refund obligation, each with its own performance trigger and its own ASC 606 timing rule.
Get the bookkeeping right, and a reproductive endocrinology practice can map its true margin per service line, price refund-guarantee programs without bleeding cash, and survive a CDC data audit without scrambling. Get it wrong, and the clinic books revenue it has not yet earned, understates a real refund liability, and walks into tax season with a profit-and-loss statement that bears little resemblance to operating reality.
This guide walks through the accounting choices that matter most for independent IVF clinics, donor programs, and fertility-preservation practices.
Why Fertility Practice Accounting Is Different
A reproductive endocrinology and infertility (REI) practice is a hybrid business. It is part professional medical service, part outpatient procedure suite, part embryology laboratory, part long-term storage warehouse, and part travel agency for donor and gestational-carrier arrangements.
Three structural features make fertility accounting unusually messy:
- Cash comes in long before the service is rendered. Patients typically pay for a full cycle, package, or multi-cycle refund program weeks or months before retrieval, and embryo storage is often prepaid annually.
- A material portion of every invoice is not the clinic's revenue. Donor compensation, agency fees, gestational-carrier payments, and outside genetic-testing labs may all flow through the clinic's books but never belong to the clinic.
- The clinic carries a contingent refund obligation in any program that promises a "take-home baby or your money back" outcome — and the size of that liability depends on probabilities, not on a fixed contract amount.
Each of these features maps to a specific accounting treatment that, if ignored, will mislead the owner, the lender, and the IRS.
The ASC 606 Framework, Applied to an IVF Cycle
ASC 606 — the revenue recognition standard issued by the Financial Accounting Standards Board — asks every business to apply a five-step model: identify the contract, identify the performance obligations, determine the transaction price, allocate that price across the obligations, and recognize revenue as each obligation is satisfied.
For an IVF clinic, that maps roughly as follows.
Step 1: Identify the contract
The patient consent and financial agreement, signed before a stimulation cycle starts, is the contract. Multi-cycle programs and refund guarantees create a single contract that spans multiple retrievals and transfers.
Step 2: Identify distinct performance obligations
A typical fresh IVF cycle includes several distinct deliverables:
- Stimulation monitoring (office visits, ultrasounds, labs)
- Egg retrieval (procedure room, anesthesia, professional fee)
- Embryology lab work (ICSI, embryo culture, biopsy)
- Embryo transfer (fresh or frozen)
- Cryopreservation and storage of unused embryos or oocytes
- Optional add-ons (preimplantation genetic testing, assisted hatching, endometrial receptivity testing)
Each of these is its own performance obligation. Booking the entire prepayment as revenue on the day a check clears is wrong; the lab has not yet cultured an embryo or frozen a blastocyst.
Step 3: Determine the transaction price
For a fixed-fee package, this is the contract amount minus expected refunds, discounts, and any variable consideration. For a refund-guarantee program, this is the expected value of the consideration the clinic actually expects to keep — which is less than the gross invoice if some patients will receive refunds.
Step 4: Allocate the transaction price
The price is allocated to each performance obligation based on standalone selling prices. A clinic with a published a-la-carte menu has those prices readily available. A clinic that only sells bundles needs to estimate a fair allocation; otherwise, every refund or partial completion becomes guesswork.
Step 5: Recognize revenue as obligations are satisfied
Stimulation monitoring revenue is recognized as each visit happens. Retrieval revenue hits the P&L the day of the procedure. Lab revenue recognizes when the embryos are biopsied or frozen. Transfer revenue recognizes at transfer. Multi-year cryostorage revenue is amortized monthly over the storage term. Every dollar collected up front sits in a contract liability account until the matching obligation is delivered.
Refund-Guarantee Programs: The Refund Liability You Cannot Ignore
Roughly half of U.S. fertility clinics now offer some form of multi-cycle or refund-guarantee program. The structure varies — three retrievals plus unlimited frozen transfers for a fixed fee, or a partial refund (often 70 to 100 percent) if no live birth occurs — but the accounting question is the same: how does the clinic recognize revenue when part of the consideration may have to be returned?
ASC 606 calls this variable consideration. The clinic should estimate the transaction price using either the expected-value method (probability-weighted average across many similar contracts) or the most-likely-amount method (the single most probable outcome). The amount the clinic will keep is recognized as revenue over the service period. The portion the clinic expects to refund is recorded as a refund liability on the balance sheet.
Practical example, simplified. Suppose a clinic charges $40,000 for a three-cycle, 80 percent refund-guarantee program. Historical data shows 70 percent of similar patients have a live birth (no refund), and 30 percent do not (80 percent refund).
- Expected refund per contract: 30% × ($40,000 × 80%) = $9,600
- Expected revenue per contract: $40,000 − $9,600 = $30,400
The $30,400 is allocated across performance obligations and recognized as the cycles are delivered. The $9,600 sits in a refund liability account, trued up as actual outcomes diverge from estimates. Skipping this step inflates revenue and equity, and produces a nasty correction the year refunds actually go out.
Two practical pitfalls to avoid:
- Not enough data to be statistically meaningful. A clinic with only a handful of refund-program patients cannot confidently estimate refund rates. In that case, ASC 606 says revenue should be constrained — recognize only the amount it is highly probable will not reverse.
- Ignoring the constraint until refunds are paid. Some clinics recognize the full prepayment, treat refunds as bad-debt expense, and discover at year-end that their P&L overstates profit by six figures.
Donor and Gestational-Carrier Pass-Through Costs: Agent vs. Principal
Donor-egg cycles can add $20,000 to $35,000 to a base fee. Donor sperm runs $400 to $2,000 per vial plus annual storage. Gestational-carrier arrangements can add $60,000 to $150,000 in agency, legal, and carrier compensation. The clinic typically collects this money and disburses it — but is it the clinic's revenue?
Usually not. ASC 606 distinguishes between an agent (collects on behalf of a third party, recognizes only the net commission as revenue) and a principal (controls the service before transfer to the patient, recognizes the gross amount). Most clinics are agents with respect to donor compensation, surrogate compensation, agency fees, and outside genetic-lab fees.
The bookkeeping mechanics:
- Funds collected for the third-party recipient hit a liability account (e.g., "Donor Compensation Payable") on receipt, not a revenue account.
- The disbursement to the donor agency or surrogate clears the liability.
- Only the clinic's coordination or administration fee, if any, is recognized as revenue.
Booking these pass-throughs as gross revenue inflates the top line dramatically and distorts every margin metric a lender or buyer would look at. It also creates state sales-tax and franchise-tax exposure in jurisdictions that tax gross receipts.
The Embryology Lab and Annual Cryostorage Subscription
The lab is the heart of the clinic. From an accounting standpoint, it is also the place with the highest mix of capital equipment and the longest revenue tail.
Capitalizing high-cost lab assets under Section 179
Time-lapse incubators ($60,000 to $150,000 each), inverted ICSI microscopes with micromanipulators, laser-assisted hatching workstations, embryo-grading software platforms, and vitrification stations all qualify for Section 179 expensing or bonus depreciation, subject to the annual cap and the clinic's taxable-income limit. Track each asset individually in a fixed-asset register with placed-in-service date, useful life, and Section 179 election noted; do not lump them under "lab equipment."
Cryostorage as recurring subscription revenue
Embryo and oocyte cryostorage is typically billed annually, often $500 to $1,200 per patient. Under ASC 606, the storage fee is a stand-ready obligation — the clinic continuously stores the specimens during the period — and revenue should be recognized ratably over the contract term, not in a lump on receipt.
A clinic that collects $1,000 on January 1 for the year's storage should book:
- Cash $1,000 / Deferred revenue $1,000 on January 1
- Deferred revenue $83.33 / Storage revenue $83.33 each month thereafter
Multiply this across hundreds of patients and the deferred-revenue balance on a fertility clinic's balance sheet is often a major liability item. Lenders look at it carefully because it represents future service obligations the clinic must still deliver.
Service Lines That Belong on Separate General-Ledger Accounts
A fertility practice that books everything under "patient revenue" cannot answer the basic management question: which service line actually makes money? At minimum, segregate the following on the chart of accounts:
- IVF cycle revenue (fresh and frozen separately)
- IUI and timed-intercourse cycle revenue
- Diagnostic and consult revenue (insured and self-pay)
- Egg-freezing and fertility-preservation revenue
- Embryo and gamete cryostorage revenue
- Preimplantation genetic testing (PGT) revenue (or pass-through if outsourced)
- Donor-egg program coordination revenue
- Donor-sperm and surrogacy coordination revenue
- Refund liability and refund expense (contra-revenue)
On the cost side, mirror these with direct-cost accounts for medications, lab supplies, anesthesia, and the per-cycle portion of embryologist labor.
Compliance Costs That Are Real Operating Expenses
Reproductive endocrinology sits at the intersection of several regulatory regimes. Each one carries recurring costs that should be tracked as their own GL line so the owner can see what compliance actually costs.
- CDC ART reporting (NASS). The Fertility Clinic Success Rate and Certification Act of 1992 requires every clinic to report each ART cycle to the National ART Surveillance System and verify the data annually. The annual reporting workload, the cost of the reporting platform, and the medical director's verification time are real operating expenses.
- FDA HCT/P regulations (21 CFR Parts 1270 and 1271). Donor eligibility determinations, infectious-disease testing, and record retention add per-cycle screening costs.
- CLIA certification for the embryology lab carries inspection and proficiency-testing fees.
- HIPAA recordkeeping drives EMR, security, and breach-notification costs.
- State medical board licensing for each physician and any embryologist credentialing through the ABB or American College of Embryology.
These should be visible line items, not buried in "office expense."
Insurance and Mandated Coverage Reconciliation
A growing list of states require some level of insurance coverage for fertility care. Insurance billing reconciliation is one of the trickiest pieces of the operation because:
- Patients may pay a self-pay package fee while also having insurance for diagnostics and labs.
- Insurance may cover monitoring but exclude lab and transfer.
- The clinic must avoid double-collecting from patient and insurer for the same service.
Best practice is to track each cycle as its own job in a sub-ledger, post insurance payments against the matching procedures, and refund or credit the patient when insurance ultimately pays for something the patient had pre-paid. Without this, refund liabilities to patients grow silently and surface only at audit.
KPIs That Tell You Whether the Practice Is Actually Working
Once the chart of accounts is clean, the operational KPIs become readable. Watch:
- Live birth per retrieval (clinic-level) versus national CDC benchmarks for the same age band
- Average revenue per fresh IVF cycle, net of pass-throughs and refunds
- Cycle gross margin (revenue minus drugs, lab supplies, anesthesia, embryologist hours)
- Embryologist utilization (cycles per embryologist FTE per year)
- Refund liability as a percent of trailing 12-month refund-program revenue
- Cryostorage deferred revenue balance and average storage-years on the books
- Days revenue outstanding for the insured-care portion of the practice
A well-run REI practice should be able to produce all of these monthly. If pulling them takes more than a day, the underlying ledger structure is the bottleneck.
Owner Compensation, Entity Structure, and the Self-Employment Tax Trap
Most independent fertility clinics are structured as professional corporations or professional LLCs taxed as S corporations, with the physician-owners receiving a reasonable salary plus distributions. Two specific tax exposures recur:
- Reasonable-compensation challenges. Successful REIs generate large profits; if the W-2 salary is too low relative to the distributions, the IRS may reclassify and assess back payroll tax. A documented benchmarking study against published REI compensation surveys helps defend the salary chosen.
- Embryologist and lab director status. Misclassifying a senior embryologist as a 1099 contractor when the role is full-time and clinic-controlled creates payroll-tax exposure and ERISA risk if benefits are involved. The state ABC test, where applicable, leans heavily toward employee status.
These are not items to optimize once a year — they should be revisited each time the practice adds a physician, opens a satellite, or restructures incentive compensation.
How Plain-Text Accounting Helps a Complex Practice Like This
A fertility clinic's accounting is unusually rich in long-lived liability balances — refund liabilities, deferred storage revenue, donor pass-through holding accounts — and unusually dependent on month-after-month consistency in how transactions are classified. Spreadsheets buckle. Vendor-lock accounting suites hide the underlying mechanics. A plain-text approach, where every journal entry is a readable line that survives software changes and supports version control, makes audit prep and revenue-reconciliation reviews dramatically easier.
Keep Your Practice's Finances Clear from Cycle One
Building a reproductive endocrinology practice that lasts means being able to see, every month, where the margin really is and where the liabilities really sit. Beancount.io provides plain-text accounting that gives you complete transparency and control over your clinic's financial data — every entry readable, every change tracked, and your data exportable on your terms. Get started for free and see why operators in complex, regulated practices are switching to plain-text accounting.